IL17A and autoimmune hepatitis: Studies have also shown that serum concentrations of IL-33 are associated with upregulated levels of IL-17A in patients with autoimmune hepatitis, whereas specific inhibition of IL-33 by treatment with a specific neutralizing antibody significantly reversed the level of IL-17A in a murine model with autoimmune hepatitis (72).